An atypical form of Asian variant of intravascular large B-cell lymphoma presenting with myelopathy alone for 4 months prior to pancytopenia.
Takizawa
Shunya
S
Division of Neurology, Department of Internal Medicine, Tokai University School of Medicine, Isehara. shun@is.icc.u-tokai.ac.jp
Shirasugi
Yukari
Y
Nakamura
Naoya
N
Nakagawa
Satoko
S
Tsuchiya
Takahide
T
Ando
Kiyoshi
K
Takagi
Shigeharu
S
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D016393:Lymphoma, B-Cell / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D010198:Pancytopenia / Q000188:drug therapy / Q000209:etiology; D010264:Paraplegia / Q000209:etiology*; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D013118:Spinal Cord Diseases / Q000209:etiology*; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone